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MAF1 is a global repressor of RNA polymerase III transcription that regulates the expression of highly abundant
noncoding RNAs in response to nutrient availability and cellular stress. Thus, MAF1 function is thought to be
important for metabolic economy. Here we show that a whole-body knockout ofMaf1 in mice confers resistance to
diet-induced obesity and nonalcoholic fatty liver disease by reducing food intake and increasing metabolic ineffi-
ciency. Energy expenditure inMaf1−/− mice is increased by several mechanisms. Precursor tRNA synthesis was
increased in multiple tissues without significant effects on mature tRNA levels, implying increased turnover in a
futile tRNA cycle. Elevated futile cycling of hepatic lipids was also observed. Metabolite profiling of the liver and
skeletal muscle revealed elevated levels of many amino acids and spermidine, which links the induction of
autophagy inMaf1−/−mice with their extended life span. The increase in spermidine was accompanied by reduced
levels of nicotinamideN-methyltransferase, which promotes polyamine synthesis, enables nicotinamide salvage to
regenerate NAD+, and is associated with obesity resistance. Consistent with this, NAD+ levels were increased in
muscle. The importance of MAF1 for metabolic economy reveals the potential for MAF1 modulators to protect
against obesity and its harmful consequences.
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In natural populations,metabolic efficiency promotes sur-
vival in stressful environments, such as when the quality
or quantity of food is limited (Parsons 2007). However, as
evidenced by the global obesity epidemic and its associat-
ed comorbidities (e.g., insulin resistance, type 2 diabetes,
cardiovascular disease, nonalcoholic fatty liver disease,
and cancer) (Guh et al. 2009; Flegal et al. 2010; Unger
and Scherer 2010), metabolic efficiency has become a lia-
bility for a large number ofmodern day humans. Reducing
obesity through diet and exercise produces health bene-
fits, but maintaining weight loss over the long term
remains a challenge for most overweight people (Krasch-
newski et al. 2010;Maclean et al. 2011), and pharmacolog-
ical approaches to reduce food intake or absorption have
undesirable side effects or safety concerns (Tseng et al.
2010; Clapham and Arch 2011). With the identification
of functional brown adipose tissue (BAT) in adult humans
and the inducible browning of white adipose tissue
(WAT), new strategies to increase energy expenditure
have emerged as promising therapies for obesity and met-
abolic disease (Harms and Seale 2013; Rosen and Spiegel-
man 2014). These approaches stimulate facultative
thermogenic responses that uncouple substrate oxidation
from ATP synthesis, dissipate the mitochondrial proton
gradient, and release chemical energy as heat. Other pos-
sibilities to enhance energy expenditure by decreasing
the metabolic efficiency of obligatory cellular processes
remain largely unexplored (Alekseev et al. 2010; Anun-
ciado-Koza et al. 2011; Oie et al. 2014).8These authors contributed equally to this work.
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Ribosome biogenesis has long been recognized as a sig-
nificant consumer of metabolic energy, with ∼60% of the
nucleotides polymerized in nuclear gene transcription of
exponentially growing cells going toward the synthesis
of the large ribosomal RNAs (rRNAs) (Warner 1999;
Grummt 2013). The energetic cost of this synthesis along
with the production of 5S rRNAand tRNAs underlies a bi-
ological imperative for tight control of these processes
in all organisms. Thus, metabolic economy is ensured
when nutrients are limiting and under various stress
conditions by regulatory systems that rapidly repress
transcription involving the protein synthetic machinery
(Warner 1999; Grummt 2013; Moir and Willis 2013). In
higher eukaryotes, repression of rDNA transcription in re-
sponse to nutrient deprivation is mediated in part by the
energy-dependent nucleolar silencing complex (eNoSC).
eNoSC binding throughout the rDNA repeat is achieved
via the nucleolar protein nucleomethylin (NML) and its
interaction with histone H3 dimethylated at Lys9. To-
gether with the action of other eNoSC subunits, a repres-
sive chromatin structure is established by the SIRT1
histone deacetylase and the histone H3methyltransferase
Suv39h1, leading to the repression of rDNA transcription
(Murayama et al. 2008). The biological importance of the
energy conservation provided by this repression is indicat-
ed by the resistance ofmicewith a liver-specific knockout
of NML to diet-induced obesity (Oie et al. 2014). In the ab-
sence of NML, increased rDNA transcription in high-fat-
fed mice promotes hepatic energy expenditure and alters
lipid metabolism, leading to reduced fat accumulation
and reduced body weight gain. Thus, repression of hepatic
rDNA transcription allows excess energy storage as fat.
MAF1 functions to promote metabolic economy by re-
pressingRNApolymerase III (Pol III) transcriptionofhighly
abundant cellular RNAs under conditions of nutrient lim-
itation and cellular stress (Upadhya et al. 2002; Reina et al.
2006). In yeast, MAF1 is required universally for this re-
sponse, and, in its absence, strains exhibit reduced fitness,
stress sensitivity, altered respiratory metabolism, and de-
creased sporulation efficiency (Cherry et al. 2012). These
phenotypes can be rationalized by the inappropriate diver-
sion of metabolic resources into the energetically costly
synthesis of 5S RNA and tRNAs, which together account
for∼15%of total RNA.MAF1 is a terminal node in the tar-
get of rapamycin (TOR) signaling network, which drives
cell growth, controls metabolism, and contributes tomet-
abolic disease, cancer, and aging (Michels et al. 2010;
Zoncu et al. 2011;Moir andWillis 2013). Thephospho-reg-
ulationofMAF1, its interactionswith theRNAPol III tran-
scription machinery, and its function in transcriptional
repression are conserved from yeast to mammals, but the
impact of its ablation has not been assessed inmetazoans.
Results
Obesity and fatty liver resistance ofMaf1−/− mice
MAF1 is encoded by a single ubiquitously expressed gene
in mice and humans (Wu et al. 2009) and was knocked
out inmouse embryonic stemcells by homologous recom-
bination (Supplemental Fig. S1A–C). Crosses of Maf1+/−
mice generated in the C57Bl/6J background produced
Maf1−/−progeny innumbers thatwerenot statistically dif-
ferent from Mendelian expectation (Supplemental Fig.
S1D). Thus, the whole-body knockout is unconditionally
viable. Interbreeding ofMaf1−/− animals revealed reduced
fertility and fecundity compared with wild-type mice
(Supplemental Fig. S1E). Maf1−/− mice appeared normal
at birth but exhibited lower body weight compared with
age-matched controls after weaning (Fig. 1A; Supplemen-
tal Fig. S1F). These differences were extreme under a
high-fat diet (HFD), as wild-type mice rapidly became
obese. In contrast, Maf1−/− mice maintained essentially
the same body weight on HFDs and regular chow diets
(Fig. 1A). Body composition analyses showed that chow-
fedMaf1−/−mice had substantially less fat as a percentage
of total body weight compared with wild-type mice, con-
sistent with the reduced size of their epididymal fat pads
(Fig. 1B,C). In older animals (>6 mo of age), differences in
body length and absolute lean body mass were also appar-
ent, suggesting an overall reduction in the growth rate of
the knockout (Fig. 1D,E). Maf1−/− mice maintained on a
HFD had little omental and subcutaneous adipose tissue
compared with controls (Fig. 1F). In contrast, epididymal
WAT (eWAT) and BAT were retained in the knockout,
yet the adipocytes did not become hypertrophic as seen
in wild-type tissue (Fig. 1G). eWAT adipocyte cell volume
wasmarkedly reduced inMaf1−/−mice on both low-fat di-
ets andHFDs (Fig. 1G,I; Supplemental Fig. S1G). These dif-
ferences in cell volume (especially for chow-fed mice)
predict larger differences in epididymal fat pad size than
were observed (Fig. 1C). However, Maf1−/− mice had al-
most twice the number of adipocytes in this fat depot as
wild-type mice (Fig. 1J). Wild-type mice fed a HFD for 6
mo and chow-fed mice at 1 yr exhibited severe hepatocel-
lular swelling due to lipid droplet (LD) accumulation in the
liver. This defining phenotype of nonalcoholic fatty liver
disease was not observed in the knockout (Fig. 1F–H; Sup-
plemental Fig. S1G). To confirm that the bodyweight phe-
notype of Maf1−/− mice was due to the loss of the MAF1
protein and was not an effect of the deletion on expression
of some other gene, Maf1-null mice were generated with
targeted zinc finger nucleases. Two different C57Bl/6J
lines were obtained: one with a single-base-pair insertion
and another with an 8-base-pair (bp) deletion. Both muta-
tions change the reading frame after Thr64, resulting in
translation termination shortly thereafter (Supplemental
Fig. S2A). Under ad libitum high-fat feeding, these Maf1-
null mice showed a dramatic resistance to weight gain
similar to that of mice lacking the entire coding region
(Fig. 1A; Supplemental Fig. S2B). We conclude that whole
body loss of MAF1 results in mice that are lean and pro-
foundly resistant to diet-induced obesity and fatty liver
disease. All subsequent experiments in this study were
performed with the complete gene knockout.
Reduced food intake and metabolic inefficiency
To explore possible factors contributing to the reduced
weight of Maf1−/− mice, we measured the fecal lipid
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content of chow-fed animals and found that malabsorp-
tion of dietary fat was not a significant factor in the lean
phenotype of the knockout (Fig. 2A). We then performed
feeding studies on weight-matched wild-type and
Maf1−/− animals and observed a reduction in food intake
in the knockout mice (Fig. 2B,C). To determine whether
this difference in behavior could explain the reduced
body weight phenotype, we pair-fed animals on a HFD
starting at 10 wk of age, a point at which there was no dif-
ference in the weight of the mice. Body weight curves di-
verged over 8 wk of HFD paired feeding, with Maf1−/−
mice being significantly lighter thanwild-typemice under
these conditions (Fig. 2D). The body fat content ofMaf1−/−
mice increased following the switch to a HFD but re-
mained significantly lower than for wild-type mice (Fig.
2E). Thus, while reduced food intakeundoubtedly contrib-
utes to the lower weight of Maf1−/− mice, it does not ac-
count entirely for this phenotype or the difference in
body fat content. These observations suggested that
wild-type andMaf1−/−micemight show differences in en-
ergyexpenditure. Indirect calorimetry studiesofHFDpair-
fed mice revealed an increase in the energy expenditure of
Maf1−/− animals, normalized for lean body mass, during
both the day and night, with the differences being greater
at night during the active period (Fig. 2F). The increase
in energy expenditure was not the result of Maf1−/−
mice beingmore active, as locomotor activity determined
by the number of infrared beam breaks in the metabolic
chambers did not reveal any differences (Supplemental
Fig. S3A). The respiratory exchange ratio was slightly ele-
vated inMaf1−/−mice during both the day and night, sug-
gestive of a marginally enhanced use of glucose as an
energy source (Supplemental Fig. S3B). Consistent with
the increase in energy expenditure, liver homogenates of
high-fat-fedMaf1−/−mice showed increased O2 consump-
tion by mitochrondrial complex 2 compared with wild-
type controls (Fig. 2G). This occurred without any in-
crease in mitochondrial DNA or changes in the cellular
levels of selected proteins in the electron transport chain
(Supplemental Fig. S3C,D). Thus,Maf1−/−mice are resis-
tant to obesity as a result of both reduced caloric intake
(feeding) and increased energy expenditure. Notably, the
diminished ability of Maf1−/− mice to transform calories
into biomass under pair feeding conditions (Fig. 2D) indi-
cates that the animals are metabolically inefficient.
Altered lipid homeostasis in livers and eWAT
Changes in metabolic efficiency could impact many pro-
cesses, including glucose or lipid homeostasis. However,
Figure 1. Maf1−/− mice exhibit resistance to diet-induced obesity and fatty liver disease. (A) Body weight curves of wild-type (WT) and
Maf1−/− (KO) animals on chow diets and HFDs. (B) Fat mass as a percentage body weight for chow-fed mice at 16 and 33 wk (n = 3 per
group). (C ) Epididymal fat pads harvested from chow-fed wild-type andMaf1−/−mice at 5 mo of age. Images are oriented with the testes
to the left. (D) Nose to anus body length of chow-fed mice (n = 8 per group at 3 mo; n = 19 per group at 6 mo of age). (E) Lean body mass of
chow-fed mice at 12 mo of age (n = 5 wild type; n = 4 knockout). (F ) Gross pathology of 7-mo-old HFD-fed mice (representative of three
animals per group). (G) Hematoxylin and eosin (H&E)-stained eWAT, BAT, and livers from the HFD-fed mice in F. Images are at the
same magnification. (H) Oil-Red-O staining of livers from 12-mo-old chow-fed mice. (I ) Estimation of adipocyte cell volumes for mice
on chow-fed diets versus HFDs (see also Supplemental Fig. S1G). (J) eWAT fat pad cell counts for 12-mo-old chow-fed mice (n = 5 per
group). (Black) Wild-type; (red)Maf1−/−. All values are presented as the mean ± SEM.
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plasma glucose levels in the chow-fed state and after an
overnight fast showed no differences between wild-type
and Maf1−/− mice at 4 mo of age, and pancreatic insulin
content and islet insulin secretion ex vivo were normal
(Fig. 3A–C). In a hyperinsulinemic–euglycemic clamp
study, Maf1−/− mice on a chow diet required higher glu-
cose infusion rates to achieve euglycemia (Fig. 3D–F)
and showed increased whole body glucose disposal as
well as increased suppression of hepatic glucose produc-
tion (Fig. 3G–J). These results indicate that Maf1−/−
mice are slightly more sensitive to insulin than control
animals. However, these differences are associated with
the lower body weight ofMaf1−/−mice (Fig. 3K). We con-
clude that insulin sensitivity is slightly increased in
Maf1−/− mice due to their lean phenotype rather than as
a direct consequence of the absence of MAF1.
Given themarked reduction in body fat inMaf1−/−mice
(Fig. 1B), we assayed for lipid metabolites in plasma. The
concentrations of free fatty acids and cholesterol were nor-
mal in chow-fed knockout mice compared with controls
(Fig. 4A,B). However, targeted metabolomics identified
distinct differences between the two groups, including re-
ductions in the levels of multiple glycerophospholipids in
Maf1−/− plasma (Fig. 4C; Supplemental Fig. S4; Supple-
mental Table S1). Basal lipolysis in eWAT explants was el-
evated in the knockout, comparable with wild-type tissue
in which lipolysis was activated by the β3-adrenergic ago-
nist CL-316243 (Fig. 4D). Notably, incubation ofMaf1−/−
eWAT with the agonist did not substantially increase
glycerol output over the untreated tissue, suggesting
that lipolysis was close to maximally stimulated (Fig.
4D). Consistentwith this possibility, the level of activated
hormone-sensitive lipase (HSL) was greater than fourfold
higher in eWAT of ad libitum chow-fedMaf1−/−mice rel-
ative to controls (Fig. 4E,F). The observation that dopa-
mine levels were elevated in the plasma ofMaf1−/− mice
(Supplementary Table S1; Supplemental Fig. 4B) raises
the possibility that activation of HSL may be achieved
via Gαs-coupled dopamineD1 receptors on the adipocytes
(Borcherding et al. 2011). Lipid metabolism was also
Figure 2. Hypophagia and metabolic inefficiency of
Maf1−/− mice. (A) Fecal lipid content of chow-fed mice
(n = 4 per group). (B) Two-day cumulative food intake of
weight-matched chow-fedmice (n = 4 per group). (C ) Dai-
ly food intake of weight-matched mice averaged over 5
d. (D) Body weight curves of pair-fed mice on a HFD (n
= 5 per group). (E) Percent body fat before and after 8 wk
of HFD pair feeding (n = 5 per group). (F ) Energy expendi-
ture in HFD pair-fed animals (24-h averages over 5 d in
metabolic cages; n = 4 per group; mice were 18 wk of
age). (G) Oxygen consumption frommitochondrial com-
plex 2wasmeasured on liver homogenates fromHFD-fed
mice (n = 8 per group). (Black) Wild-type (WT); (red)
Maf1−/− (KO). All values are presented as the mean ±
SEM.
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altered in the livers ofMaf1−/− mice, which displayed in-
creased de novo lipogenesis (Fig. 4G). Thus,Maf1−/−mice
exhibit altered lipid metabolism in the liver andWAT and
a different profile of glycerophospholipids in plasma.
Energy expenditure associated with futile synthesis
of tRNA
To investigate global changes in gene expression in a tis-
sue exhibiting Maf1−/− phenotypes, deep sequencing
was performed on eWAT RNA. Although MAF1 has
been reported to regulate transcription of several pro-
tein-coding genes (Johnson et al. 2007; Palian et al.
2014), we did not identify any significant, reproducible
changes in the Pol II transcriptome in this tissue (Supple-
mental Fig. S5A; Supplemental Table S2). Importantly, al-
though the observed increase in energy expenditure could
in principle reflect higher levels of adaptive thermogene-
sis, we observed no induction of known activators or
markers of BAT or beige adipose tissue, including UCP1,
which regulates proton leak in thermogenic tissues (Wal-
den et al. 2012; Wu et al. 2012; Harms and Seale 2013). In-
deed,Western blotting showed that UCP1was unchanged
in BAT and undetectable in eWAT (Supplemental Fig.
S5B–D), and the body temperature and cold stress resis-
tance of Maf1−/− mice was normal (Supplemental Fig.
S5E,F). These observations suggest that enhanced energy
dissipation in Maf1−/− mice does not result from recruit-
ment of brown-like adipocytes inWATorUCP1-mediated
uncoupling of oxidative phosphorylation.
Previous studies of Maf1 knockdown and overexpres-
sion in glioblastoma cells found inverse changes in the ex-
pression of the TATA-box-binding protein (TBP) at the
RNA and the protein level that correlated with changes
in RNA Pol I transcription (Johnson et al. 2007). MAF1 ef-
fects on TBP expression were due to its recruitment to
the TBP promoter, whereas changes at the rDNA were
thought to be mediated by the promoter selectivity factor
SL1, which contains TBP as a central component
(Grummt 2013). Although TBP expression was not affect-
ed in Maf1−/− eWAT RNA (Supplemental Table S2), we
examined this issue further in Maf1−/− livers and also
Figure 3. Blood glucose, insulin secretion, and analysis of insulin sensitivity. (A) Blood glucose concentrationswere determined from tail
vein bleeds after an overnight fast and following a 4-h refeed. Mice were 4 mo of age and were maintained on a breeder chow diet. (n = 7
mice per group). (B) Insulin secretion ex vivo was assayed in the presence of 2 mM and 20 mM glucose (five islets per well; n = 8 per con-
dition per genotype; chow diet). Results are expressed as a percentage of the total insulin content of the islets used in the assay. (C ) Insulin
content of islets was calculated from five islets per sample (n = 16 per group). (D–K ) Hyperinsulinemic–euglycemic clamp analysis of in-
sulin sensitivity in 5-h-fasted mice. (D) Plasma glucose levels before and during the clamp. (E) Plasma insulin levels before and during the
clamp. (F ) Glucose infusion (GINF) rate needed tomaintain euglycemia. (G) Glucose disposal rate (GDR) before and during the clampwas
measured by the tracer dilution technique using [3-3H]glucose as tracer. (H) Hepatic glucose production (HGP) during the clamp. (I ) Sup-
pression of hepatic glucose production was calculated as the difference in HGP in the basal state (=basal GDR) and during the clamp di-
vided by the basalHGP. (J) Rates of glucose disposal versus glucose infusion are shown for all of themice in the study relative to a linewith
a slope of 1. HGP is the vertical difference between each data point and the line. (K ) Glucose infusion rate (insulin sensitivity) is inversely
correlatedwith the bodyweight of themice. A linear fit is shown to all of the data. All values are presented as themean ± SEM.Clamp data
in D–K were obtained from 13 wild-type and 12Maf1−/− mice. (Black) Wild type (WT); (red)Maf1−/− (KO).
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looked for changes in rDNA transcription (Supplemental
Fig. S5G–I; Oie et al. 2014). No significant differences
were detected in these assays. We infer that the effects
of MAF1 on TBP expression and potentially other protein
coding genes may be context-dependent.
eWAT RNA sequencing (RNA-seq) data were analyzed
to determine the effect of the knockout on the synthesis
of precursor tRNAs. These molecules are short-lived and
are widely used to assess the level of transcription by
RNA Pol III (Upadhya et al. 2002; Michels et al. 2010).
Consistent with the increase in polymerase occupancy
of Pol III genes in Maf1−/− tissue (Bonhoure et al. 2014),
pre-tRNA-specific reads representing >100 different
tRNA genes were markedly increased in the knockout
(Fig. 5A; Supplemental Table S3). In contrast, mature
tRNA-specific reads increased significantly for only a
few tRNA genes, and the magnitude of these changes
was much lower (Fig. 5B; Supplemental Table S3). Similar
findings were obtained byNorthern blotting of tRNA spe-
cies fromWATand numerous other tissues (Fig. 5C,D; Ta-
ble 1). For example, pre-tRNAIle (TAT) levels increased
from approximately threefold in the liver and quadriceps
to approximately ninefold in WAT and the spleen, while
the levels of five different mature tRNAs, including initi-
ator methionine tRNA (tRNAi
Met), in various tissues
showed only minor variations (Fig. 5C,D; Table 1). Addi-
tionally, quantitation of the tRNA fraction in the liver in-
dicated only amodest 15%± 3% increase in the knockout
(P = 0.008, n = 7 per group), and total tRNA levels in a
range of other tissues showed minimal changes (Supple-
mental Fig. 5J). Mature tRNA is reported to have a long
(2- to 3-d) half-life in chicken livers and mouse uteruses
(Miller 1973; Nwagwu and Nana 1980), so a large (greater
than threefold) increase in Pol III transcription in the ab-
sence of MAF1 (Fig. 5A,C,D) should have been readily ap-
parent in the steady-state abundance of the mature tRNA
population. Since most mature tRNAs as well as bulk
tRNA levels were not substantially affected (Table 1;
Fig. 5B–D; Supplemental Fig. 5J), we conclude that in-
creased tRNA synthesis in the knockout must be largely
matched by increased turnover of nascent tRNA tran-
scripts, pre-tRNAs, and/or mature tRNAs. Support for
Figure 4. Altered lipidmetabolism inMaf1−/−mice. (A,B) Serum-free fatty acids and serum cholesterol weremeasured in overnight-fast-
ed mice maintained on a standard chow diet (n = 6 per group). (C ) Hierarchical clustering of plasma metabolite profiles from Biocrates
AbsoluteIDQ p180 analysis performedwith mice on a breeder chow diet. The top 20metabolites by t-test (P < 0.025) were clustered using
Pearson’s correlation to measure similarity and Ward’s linkage to minimize the sum of the squares of the clusters (MetaboAnalyst) (see
also Supplemental Figure S4 and Supplemental Table S1). (D) Lipolysis in eWAT explants frommice on a breeder chow diet. Glycerol re-
lease in explantswasmeasured in the presence and absence of the β3-adrenergic receptor agonist CL-316,243 (CL, n = 8 for wild-type under
both treatments; n = 7 for untreatedMaf1−/−; n = 4 for CL-316,243-treatedMaf1−/− explants). (E) Western blot of phospho-HSL (P-HSL) and
total HSL from eWAT. (F ) Quantitation of activated phospho-HSL over total HSL in eWAT (wild type, n = 8;Maf1−/−, n = 7; breeder chow
diet). (G) De novo lipogenesis and cholesterol synthesis in livers from mice on a breeder chow diet were measured by tracer enrichment
after 5 d of receiving 6% D2O in drinking water (n = 5 per group). All values are presented as the mean ± SEM.
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this view is provided by in vivo 32P pulse-labeling of liver
RNA. Compared with the Pol I-derived 5.8S rRNA, label-
ing of Pol III-derived 5S rRNAwas unaffected, and labeling
of the newly synthesized mature tRNA population in-
creased twofold (Fig. 5E); i.e., less than the threefold level
measured for specific precursor tRNAs in this tissue (Ta-
ble 1), suggesting that some turnover has occurred. In ad-
dition, since tRNA synthesis during the pulse was
increased twofold but steady-state tRNA levels were not
substantially changed (Supplemental Fig. 5J), tRNA turn-
over is again indicated. We conclude that increased syn-
thesis and turnover of Pol III transcripts—most notably
tRNAs, which account for ∼10% of total RNA—consti-
tutes a futile cycle that is likely to be an important driver
of energy expenditure in mice.
Spermidine, autophagy, and life span extension
Wehypothesized that a pervasivewhole-body effect of the
Maf1 knockout on Pol III transcription and energy ex-
penditure was likely to generate a commonmetabolic sig-
nature in different tissues. To assess this possibility, we
conducted targeted metabolite profiling in liver and skel-
etal muscle. Multivariate partial least squares discrimi-
nant analysis (PLS-DA) of the aggregated data showed
that wild-type and knockout tissues are readily distin-
guished by their metabolite profiles (Fig. 6A). Multiple
statistical measures (variable importance in projection
[VIP] scores and t-tests) indicate that Maf1−/− tissues
have significantly elevated levels of many amino acids
and polyamine pathwaymetabolites, including ornithine,
putrescine, and spermidine (Fig. 6B; Supplemental Fig.
S6B; Supplemental Table S1). Perturbations of polyamine
synthesis have been linked to changes in adiposity (Jell
et al. 2007; Pirinen et al. 2007), and mice expressing re-
duced levels of nicotinamide N-methyltransferase
(NNMT), which influences polyamine synthesis, are obe-
sity-resistant (Kraus et al. 2014). Consistent with these
observations and the increased level of spermidine in
Maf1−/− tissues, the expression of Nnmt mRNA was
significantly reduced in the liver, as was the level of
NNMTprotein in the liver andmuscle (Fig. 6C,D; Supple-
mental Fig. S6C,D). NNMTmethylates nicotinamide us-
ing S-adenosyl methionine (SAM) as a methyl donor.
Thus, in addition to its potential to affect SAM-dependent
methylation reactions and the supply of propylamine
groups for polyamine synthesis, NNMT can regulate the
availability of NAD+ for cellular redox metabolism (Sup-
plemental Fig. S6A; Kraus et al. 2014). To examine this
issue, we measured the total cellular concentration of
NAD+ inwild-type andMaf1−/− livers and skeletalmuscle
by liquid chromatography-mass spectrometry (LC-MS).
Consistent with the view thatNAD+ synthesis in the liver
is not limited by the activity of the nicotinamide salvage
pathway (Houtkooper et al. 2010; Kraus et al. 2014), the
level of NAD+ in Maf1−/− livers was the same as for
wild-type tissue (Fig. 6E). In contrast, the level of NAD+
was increased ∼40% in Maf1−/− muscle (Fig. 6E). Similar
increases have been reported in the muscles of mice
with a whole-body deletion of poly(ADP-ribose) polymer-
ase, a major consumer of NAD+, and in mice whose diet
has been supplemented with theNAD+ precursor nicotin-
amide ribonucleoside (Cantó et al. 2012; Houtkooper et al.
2012). Importantly, these animal models have increased
energy expenditure and are protected from HFD-induced
obesity. In light of these studies, it appears likely that
Figure 5. Futile cycling of tRNAs as a mechanism for energy ex-
penditure. (A) Log ratio versus abundance (MA plot) of uniquely
mapped precursor tRNA-specific RNA-seq reads in eWAT of
breeder chow-fedmice (n = 3 per group). Yellowand red dots corre-
spond to loci exhibiting significant changes called by limma or
GLM, respectively. Browndots correspond to lociwith significant
changescalled bybothmethods.Graydots correspond to lociwith
scores that are not statistically different. (B) MA plot of uniquely
mapped mature tRNA reads in eWAT. The color scheme is the
same as in A. (C ) Northern blots of precursor and mature tRNA
species from the eWAT and livers of breeder chow-fed mice. The
fold change normalized to U3 snRNA is shown below each panel.
(D) Precursor tRNAIle (TAT) n-Ti16 (maroon), mature tRNALeu
(AAG) (green), and mature tRNAi
Met (CAT) (orange) levels were
surveyed by Northern analysis in the indicated tissues of breeder
chow-fedmice.The fold changewas normalized toU3 snRNA. (E)
Newly synthesized 5.8 S rRNA, 5S rRNA, and tRNAs from
breeder chow-fed mice were quantified in total liver RNA follow-
ing i.p. injection of 32P-orthophosphate and labeling for 4 h.
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altered NAD+ metabolism contributes to the obesity re-
sistance of Maf1−/− mice.
Spermidine is a known inducer of autophagy in yeast,
flies, worms, and mammalian cells, and enhanced auto-
phagy is critical for the life span-extending effects of
spermidine in these organisms (Eisenberg et al. 2009).
Accordingly, livers from overnight-fasted Maf1−/− mice
displayed increased autophagic activity compared with
controls, as shown by the elevated delivery of LC3-II-pos-
itive autophagosomes to lysosomes (net LC3-II flux) and
their subsequent lysosomal fusion (Fig. 6F–H; Klionsky
et al. 2007). Lysosomal degradation of proteins is consis-
tent with the observed increase in amino acid levels
(Fig. 6B; Supplemental Fig. S6B; Supplemental Table S1).
In addition, enhanced autophagic activity in the knockout
was also associated with increased colocalization of LC3
with BODIPY-stained LDs and increased sequestration
of hepatic LDs by LC3-II-positive autophagosomes (Fig.
6I,J). Moreover, we observed a significant reduction in he-
patic triglycerides but not free hepatic glycerol inMaf1−/−
mice (Fig. 6K,L). Together, these findings indicate activat-
ed mobilization of hepatocellular lipids via lipophagy
(Singh et al. 2009). Increased lipid consumption through
autophagy together with the increase in de novo lipogen-
esis in the Maf1−/− liver (Fig. 4G) reveals contributions
to metabolic inefficiency and energy expenditure in the
mice via increased futile cycling of hepatic lipids. Finally,
Kaplan-Meier survival curves revealed a statistically sig-
nificant extension of mean and maximal life span for
female Maf1−/− mice, in accordance with the effects of
spermidine and autophagy in other model organisms
(Fig. 6M; Eisenberg et al. 2009). A similar trend was ob-
served for male mice (Supplemental Fig. S6E).
Discussion
Our work shows that the loss ofMaf1, a ubiquitous global
regulator of transcription by RNA Pol III, significantly
impacts whole-body metabolism and energy expenditure
while providing health benefits. These benefits include
resistance to diet-induced obesity and nonalcoholic fatty
liver disease as well as an extension of life span that can
be attributed to previously documented effects of spermi-
dine on the induction of autophagy and longevity in yeast,
flies, andworms (Eisenberg et al. 2009). Obesity resistance
inMaf1−/− mice is achieved through reduced food intake
and increased metabolic inefficiency. In this study, we fo-
cused on the metabolic component. At the whole-body
level, Maf1−/− mice demonstrate metabolic inefficiency
by their reduced growth rate under paired-feeding condi-
tions (i.e., lower bodyweight despite equal caloric intake).
At the molecular level, metabolic inefficiency is apparent
from the increased synthesis and turnover (futile cycling)
of tRNAs and hepatic lipids. We infer that the increased
energetic cost of these processes alters the balance be-
tween fuel utilization and storage and contributes to the
lean phenotype. Additional factors contributing to the
energy expenditure and obesity resistance of the mice in-
clude the reduced expression of NNMT in the liver, mus-
cle, and potentially other tissues and downstream effects
on NAD+ metabolism and/or the polyamine pathway
(Kraus et al. 2014; Liu et al. 2014). How the different mo-
lecular effects of the Maf1 knockout are partitioned in
terms of energy expenditure and obesity resistance has
yet to be determined, but our current results already estab-
lish MAF1 as a novel and unconventional therapeutic tar-
get for the treatment of obesity and related diseases.
Reduced expression of Nnmt, which we observed in
the liver and muscle but not in eWAT, can increase the
level of SAM and/or SAM/SAH ratios and the supply of
nicotinamide (Supplemental Fig. S6A; Kraus et al. 2014).
Increased SAM levels in turn can lead to increased
polyamine synthesis, and, indeed, the liver and muscle
showed increased levels of polyamine pathway metabo-
lites, including spermidine. Perturbations of polyamine
pathway flux are associated with obesity resistance or
sensitivity in several mouse models (Jell et al. 2007; Piri-
nen et al. 2007; Kraus et al. 2014; Liu et al. 2014). In addi-
tion to oligonucleotide-directed knockdown of Nnmt,
which confers obesity resistance primarily by affecting
Nnmt expression in the liver and adipose tissue (Kraus
et al. 2014), whole-body changes in polyamine catabolism
have been engineered by overexpression and underexpres-
sion of spermidine/spermine-N1-acetyltransferase (SSAT)
(Supplemental Fig. S6A). By increasing or decreasing
polyamine acetylation in these models, acetyl-CoA and
malonyl CoA pools were altered with corresponding
changes in fatty acid synthesis, fatty acid oxidation, and
body fat accumulation. These studies implicate enhanced
polyamine pathway cycling in the obesity resistance of
Maf1−/− mice.
Elevated nicotinamide supply resulting from decreased
Nnmt can lead to increased NAD+ levels (Kraus et al.
2014), which we observed in muscle tissue. Multiple ge-
netic and pharmacological interventions that raise the
level of NAD+ are known to enhance oxidative metabo-
lism and provide protection against diet-induced obesity
(Bai et al. 2011; Cantó et al. 2012; Pirinen et al. 2014).
Along with its role as a cofactor in oxidoreductase
Table 1. Quantitation of Northern blotting data on liver RNA
tRNA species Maf1+/+ Maf1−/− P-value
Pre-tRNAIle n-Ti16 1.00 ± 0.08 (6) 2.98 ± 0.09 (6) 0.00032
Pre-tRNATyr n-Ty2 1.00 ± 0.31 (3) 3.28 ± 0.28 (5) 0.002
Pre-tRNALeu n-Tl12 1.00 ± 0.12 (3) 3.09 ± 0.31 (5) 0.0027
Mature tRNALeu (CAA) 1.00 ± 0.09 (6) 1.05 ± 0.07 (6) 0.71
Mature tRNAMeti
(CAT)
1.00 ± 0.10 (6) 1.04 ± 0.09 (6) 0.77
Mature tRNAGlu (CTC) 1.00 ± 0.01 (3) 1.06 ± 0.05 (5) 0.4
Mature tRNALeu (AAG) 1.00 ± 0.07 (3) 1.02 ± 0.02 (5) 0.74
Mature tRNASer (GCT) 1.00 ± 0.15 (3) 0.83 ± 0.08 (5) 0.28
U6 snRNA 1.00 ± 0.05 (6) 1.09 ± 0.03 (6) 0.18
U1 snRNA 1.00 ± 0.16 (6) 1.06 ± 0.09 (6) 0.75
Oligonucleotide probes to various precursor and mature tRNAs
as well as U6 and U1 snRNAs were used to quantify RNA levels
in total liver RNA preparations from overnight-fasted mice. Hy-
bridization signals were normalized to U3 snRNA as in Figure 5.
The number of biological replicates is given in parentheses.
Obesity resistance ofMaf1 knockout mice
GENES & DEVELOPMENT 941
reactions, NAD+ is a rate-limiting cosubstrate for the sir-
tuin family of NAD+-dependent deacetylases, which regu-
late the activity of several key transcription factors
controlling nuclear and mitochondrial metabolism
(Houtkooper et al. 2012). Our RNA-seq analysis of
Maf1−/− eWAT did not find any significant changes in
gene expression for SIRT1 target genes (or other protein-
coding genes), but sinceNnmt expressionwas not affected
in this tissue, NAD+ levels may not have been elevated.
Gene expression and metabolic profiling of additional
Maf1−/− tissues will further clarify the relationship be-
tween NNMT, NAD+, and metabolism in these mice.
Figure 6. Elevated amino acid and polyamine levels inMaf1−/− tissues correlate with induction of autophagy and life span extension. (A)
Two-dimensional score plot of principal components fromPLS-DAof liver and skeletalmusclemetabolite profiles frommice on a breeder
chow diet. The variance explained by each component is in brackets. Ellipses define regions of 95% confidence. (Green) Wild type (WT);
(red) knockout (KO). (B) VIP scores (>1.0 is considered significant) obtained by PLS-DA are plotted against the fold change in metabolite
concentration (normalized per milligram of tissue) in quadriceps. All metabolites had P-values <0.05 (n = 5 per group). (Green) Putrescine
and spermidine; (orange) amino acids; (maroon) glycerolphospholipids; (blue) C5 acylcarnitine. (C ) RT-qPCR analysis of polyamine path-
way gene expression in the livers (n = 5 per group) of chow-fedmice. (D) NormalizedNNMT protein levels from Supplemental Figure 6, C
andD (n = 3 per group, chow-fedmice). (E) NAD+ levels in the liver and quadriceps as determined by LC-MS (n = 5 per group, breeder chow-
fedmice). (F ) Examination of autophagic flux in liver explants frommice on a breeder chow diet. The level of LC3-II, the lipidated autopha-
gosome-associated formofLC3,wasmonitored in thepresenceorabsenceof lysosomal inhibitors (Inh).A representativeblot is shown from
three biological replicates per genotype. (G) Net flux shows the normalized difference in LC3-II ± Inh for each genotype (n = 3 per group). (H)
Rate of autophagolysosome fusion compares the normalized ratio of LC3-II ± Inh. (I ) Immunoblots of liver homogenates (Hom) andhepatic
LD fractions. PLIN2 shows the equivalence of LD content, and GAPDH shows the lack of cytosolic contamination. (J) Colocalization
(white) of BODIPY 493/503-stained LDs (green) and LC3 (red) in overnight-fasted livers. Images are at the samemagnification and are rep-
resentative of data from four wild-type and threeMaf1−/−mice. (K ) Quantitation of liver glycerol (n = 4 per group). (L) Quantitation of liver
triglycerides (n = 4 per group). The data in F–L were from the same cohort of breeder chow-fed mice. (M ) Kaplan-Meier survival curves of
female mice on a breeder chow diet (mean life span of wild type 113 wk, n = 35 [black]; mean life span of Maf1−/− 121 wk, n = 33 [red];
P = 0.0054, log rank test;maximal life span assessed on the oldest quartile: 130wk forwild type and 146wk forMaf1−/−;P = 0.00013, t-test).
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The finding that the synthesis of precursor tRNAs can
be increased 10-fold or more, depending on the gene and
the tissue, without significant changes at the level of ma-
ture tRNA suggests the existence of a robust homeostatic
mechanism to prevent the global accumulation of these
molecules. Although we did not explore the mechanism
of tRNA turnover, it seems likely that the large amount
of precursor tRNAs generated in theMaf1 knockout leads
to defects in tRNA processing and/or modification, and
such molecules—in particular hypomodified tRNAs—
are known to be rapidly degraded (Kadaba et al. 2004;
Alexandrov et al. 2006; Chernyakov et al. 2008; Wilusz
et al. 2011). Even with rapid tRNA turnover largely offset-
ting elevated precursor tRNA synthesis, subtle changes in
the composition of the tRNA pool in the knockout are
likely (Dittmar et al. 2006; Ciesla et al. 2007; Pang et al.
2014), and this in turn has the potential to alter the expres-
sion of genes whose codon usage is sensitive to these
changes (Gingold et al. 2014). The recent identification
of unique translational programs for proliferation and dif-
ferentiation genes that reflect differences in codon usage
and corresponding changes in the tRNA pool (Gingold
et al. 2014)maywell apply in other situations such asmet-
abolic disease and the response to stress. In this regard,
it is likely significant that the effect of deleting Maf1 on
Pol III gene transcription is not equal among different tis-
sues and thus may lead to tissue-specific effects on gene
expression.
The lower growth rate of Maf1−/− mice is consistent
with their reduced feeding and metabolic inefficiency
but is strikingly different from the increased cell growth
and accelerated larval development seen upon Maf1
knockdown in Drosophila (Rideout et al. 2012). Im-
portantly, these Drosophila phenotypes were recapitulat-
ed in flies overexpressing tRNAi
Met, which promoted
growth by stimulating protein synthesis. Our examina-
tion of tRNAi
Met levels in multiple mouse tissues found
no evidence of its overexpression and thus provides a
logical explanation for the growth-related phenotypic
difference.
The normal levels of tRNAi
Met inMaf1−/−mice are also
consistent with these mice not being prone to tumorigen-
esis, as demonstrated by their extended life span. Until
now, the tumorigenic potential of a Maf1 knockout in
mammals has been an open, intriguing question given
(1) substantial correlative data linking deregulated Pol III
transcription and increased tRNAi
Met levels to cell trans-
formation and tumorigenesis (White 2008; Pavon-Eternod
et al. 2013), (2) the requirement for elevated levels of Pol III
transcripts for Myc-driven tumorigenesis (Johnson et al.
2008), and (3) the ability of Maf1 overexpression to sup-
press anchorage-independent growth of transformed cells
and tumor formation in a xenograft mouse model (John-
son et al. 2007; Palian et al. 2014). While the mouse
Maf1 knockout does not promote tumorigenesis or add
to the role of Pol III transcription in the development of
cancer, the likely explanation and important insight is
that not all interventions that increase Pol III synthesis
are capable of increasing the level of tRNAi
Met or otherma-
ture tRNAs.
Studies in mammalian cells and worms have recently
reported that perturbing the expression ofMAF1 affects li-
pogenesis (Khanna et al. 2014; Palian et al. 2014). Notably,
RNAi-mediated knockdown of MAF1 increased de novo
lipogenesis in these studies, consistent with our observa-
tions in the livers ofMaf1−/−mice (Fig. 4G). However, the
apparentmechanism and the net effect on lipid accumula-
tion in these studies differ from our findings. Whereas
Maf1 overexpression or knockdown had reciprocal effects
on the mRNA levels of key lipogenic enzymes (e.g., fatty
acid synthase [FASN]) in worms and mammalian cells
(Khanna et al. 2014; Palian et al. 2014), we did not detect
significant changes in FASN expression in the liver by
either RT-qPCR or Western blotting (RD Moir and A
Byrnes, unpubl.). Also, liver triglycerides were lower
(Fig. 6L), not higher, in the knockout mice, in keeping
with the induction of lipophagy, the increase in whole-
body energy expenditure, and the lean phenotype. At the
present time, we can only speculate about the basis of
the differences between our results and these other stud-
ies. Possibilities include partial versus complete ablation
of Maf1, differences in diet and/or nutrients supplied in
growth media, and effects due to short-term versus long-
term changes in gene expression and/or metabolism.
The obesity and fatty liver disease resistance of the
whole-body Maf1 knockout may have, in part, a basis in
metabolic inefficiency similar to that of the liver-specific
knockout of NML. Hepatic NML deficiency leads to obe-
sity resistance due to a failure to repress rDNA transcrip-
tion by RNA Pol I, the main consumer of nucleotides
among the RNA polymerases (Oie et al. 2014). This effect
is extreme on a HFD. Thus, it appears that the normal
function of NML and MAF1 in transcriptional repression
by RNA Pol I and Pol III, respectively, is critical for the
conservation ofmetabolic energy and the storage of excess
calories as fat. The liver-specific phenotype of the NML
knockout coupled with differences in nucleotide con-
sumption betweenPol I and Pol III (∼60%vs. 15% in grow-
ing cell populations) argues that a knockout ofMaf1 in any
single tissue is unlikely to generate the full complement of
phenotypes or provide the same level of protection against
diet-induced obesity as the whole-body knockout. For
MAF1, the overall health benefit is likely to be derived
from reducing food intake and spreading the increase in
energy expenditure over virtually every cell in the body.
In summary, our findings indicate that obesity resis-
tance inMaf1−/−mice is achieved throughmultiplemech-
anisms. In addition to the loss of repression of RNA Pol III
transcription and the futile cycling of tRNAs in the whole
animal, other contributions to energy expenditure are pro-
vided by the futile cycling of hepatic lipids and potentially
polyamines, with enhanced oxidative metabolism en-
abled by the elevated level of NAD+. Both direct and indi-
rect effects of the Maf1 knockout on gene expression are
involved, and we suggest that changes in some processes
may be driven by an increase in the demand for nucleo-
tides. Finally, we note that the lower caloric intake of
the mice may be due to the loss of MAF1 function in the
brain and/or may reflect a differential response of the
CNS to factors secreted from peripheralMaf1−/− tissues.
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Materials and methods
Animals
All experiments involving mice were performed using protocols
approved by the Institutional Animal Care and Use Committee
(IACUC) of the Albert Einstein College of Medicine or the Veter-
inary Office of the Canton of Vaud (SCA-EXPANIM, Service de la
Consommation et des Affaires Vétérinaires, Epalinges, Switzer-
land) in accordance with the Federal Swiss Veterinary Office
guidelines. Maf1+/− mice were generated in the C57Bl/6J back-
ground (Ozgene). Details of the targeting vector, breeding,
housing, and diets are given in the SupplementalMaterial. All ex-
periments were performed with male mice except for body
weight (growth rate) and life span studies, which were performed
with animals of both sexes.
Histology and cell size and cell number determination
Adipose and liver samples were fixed in 10% buffered formalin
prior to paraffin-embedding, sectioning, and staining by hematox-
ylin and eosin (H&E). Livers were frozen in OCT cryo-embedding
medium for Oil-Red-O staining. Adipose cell volume was deter-
mined from measurements of the cell radius (>250 cells per con-
dition, two mice per genotype, v = 4/3πr3). Error estimates of the
cell radius were propagated to volume as 4πr2. Cell numbers were
determined by dissecting and weighing eWAT fat pads from
chow-fed mice (12 mo of age). A tissue sample (100 mg) was di-
gested with collagenase, the mixture was centrifuged at 200g
for 10 min, and the cells in the supernatant were counted in a
hemocytometer.
Body composition, fecal lipids, and indirect calorimetry
Body composition was determined by EchoMRI. The lipid con-
tent of mouse feces was determined by gravimetry with [14C]
triolein as a radioactive tracer to normalize for the recovery
of neutral lipids (Argmann et al. 2006). Measurements of food
intake, oxygen consumption, CO2 production, respiratory ex-
change ratio (RER), and locomotor activity were performed using
an indirect calorimetry eight-cage system (Oxymax) as described
in the Supplemental Material.
Mitochondrial respiration
Oxygen consumption in liver homogenates of HFD-fed mice was
measured using the Oxygraph-2k (Oroboros Instruments). Mito-
chondrial complexes 1 and 2 were stimulated by injection of 5
mM pyruvate, 2 mM malate, 10 mM glutamate, 2.5 mM ADP,
and 10mMsuccinate followed by inhibition of themitochondrial
complex 1 by injection of 0.5 μM rotenone.
Insulin secretion and content
Pancreatic islets were isolated from 17-wk-old mice by digestion
with collagenase and separation of exocrine tissue (Gotoh
et al. 1987). After 24 h in suspension culture, the islets were dis-
tributed into wells (five islets per well) of a 12-well plate, incub-
ated for 1 h at 37°C at a low-glucose concentration (2.8 mM),
transferred intowells containing 2 or 20mMglucose in triplicate,
and incubated for another hour. The islets were then separated
from the supernatant and lysed in acidic ethanol to extract the in-
sulin. Insulin content of the islets and the supernatant was deter-
mined, and insulin secretion was expressed as percent of insulin
content.
Hyperinsulinemic–euglycemic clamp
A dual tracer clamp ([3-3H]glucose infusion and 2-deoxy-d-[1-14C]
glucose bolus) was performed in 3-mo-old male mice. Mice re-
ceived an indwelling silicone catheter in the femoral vein and
were allowed to recover for 4–7 d before a hyperinsulinemic–
euglycemic clamp study was conducted (see the Supplemental
Material). Rates of basal and insulin-stimulated glucose disposal
and hepatic glucose productionwere determined by the [3-3H]glu-
cose dilution method.
Metabolite profiling
Biocrates AbsoluteIDQ p180 analysis of metabolites in plasma
was performed according to the manufacturer’s instructions.
Plasma was prepared from retroorbital bleeds of overnight-fasted
mice (19 wk of age). Tissue samples from overnight-fasted mice
(22–24 wk of age) were freeze-clamped in liquid nitrogen and
ground to powder with a mortar and pestle on dry ice. The pow-
dered tissue (50–100 mg) was extracted for analysis. NAD+ levels
were determined by LC-MS. Metabolites with CVs >30% were
excluded from the analysis. Supervised PLS-DA was performed
using MetaboAnalyst or SIMCA-P software.
Assays of lipogenesis and lipolysis
Lipogenesis and cholesterol synthesis were measured with deu-
terated water as a tracer (Vaitheesvaran et al. 2012). Mice were
provided with 6% D2O in their drinking water for 5 d. Palmitate
in liver triglyceride and cholesterol was analyzed by gas chroma-
tography-MS (GC-MS) to determine D2O enrichment relative to
body water. Lipolysis assays were performed on epididymal fat
pads harvested from preprandial ad libitum-fed mice (Marcelin
et al. 2012). Glycerol concentration was measured using a color-
imetric assay kit (Cayman Chemical).
Tissue extracts and Western blotting
BAT and WAT were homogenized in lysis buffer (50 mM Tris-
HCl at pH 7.4, 1 mM EDTA, 1 mM EGTA, 50 mM NaF, 10 mM
sodium glycerophosphate, 20 mM sodium pyrophosphate) con-
taining Complete Mini and PhosSTOP (Roche). Samples were
spun at 14,000g for 15 min at 4°C, and the interphase was trans-
ferred to a new tube. Triton was added to 1% (v/v), and samples
were incubated for 30 min at 4°C with agitation and then centri-
fuged as above to obtain the supernatant. Extracts from other tis-
sues were prepared in RIPA buffer with inhibitors. Protein
concentrations were determined by BCA assay (Pierce). Details
of the antibodies used are provided in the SupplementalMaterial.
RNA-seq analysis
Epididymal adipose tissue was harvested and freeze-clamped in
liquid nitrogen from overnight-fasted 22- to 24-wk-old mice
maintained on a breeder chowdiet. Total RNAwas prepared (Qia-
gen miRNeasy) and digested with DNase I, and RNA quality was
assessed by capillary electrophoresis (Agilent 2100 Bioanalyzer).
Library preparation and directional RNA-seq were performed at
the Einstein Epigenomics Core Facility. Data analysis is de-
scribed in the Supplemental Material. RNA-seq data have been
deposited in NCBI’s Gene Expression Omnibus under accession
number GSE65976.
Northern blotting and in vivo labeling of RNA
Tissue samples (50–100 mg, flash-frozen in liquid N2) were
homogenized into Qiazol lysis reagent (Qiagen), and RNA was
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purified according to the manufacturer’s directions. RNA was
precipitated twice, quantified, and resolved by denaturing poly-
acrylamide electrophoresis before electrophoretic transfer to
Nytran Plus membranes (GE Healthcare) and hybridization
with [32P]-end labeled oligonucleotide probes at 42°C (Li et al.
2000). tRNA signals detected by phosphorimaging were quan-
tified and normalized to U3 snRNA to compare expression
in wild-type and knockout samples. For in vivo labeling, mice
(23 wk of age) maintained on a breeder chow diet were fasted
overnight and injected i.p. with 0.5 mCi 32P-orthophosphate
(carrier-free) in Tris-buffered saline. After 4 h, the animals were
sacrificed, tissues were dissected and freeze-clamped, and total
RNA was prepared for electrophoresis on denaturing polyacryl-
amide gels.
Autophagy assays
In vivo LC3 autophagic flux analyses determined the amount of
LC3-II that accumulates in lysosomeswhen exposed to lysosomal
inhibitors, 20 mM ammonium chloride, and 100 μM leupeptin.
Briefly, freshly harvested liver explants were rapidly placed in
dishes containing high-glucoseDMEMin the presence or absence
of inhibitors and transferred to a CO2 incubator for 2 h at 37°C
and 5%CO2. Following incubation, explant lysates were generat-
ed and subjected to immunoblotting for LC3. Autophagic flux,
expressed as rate of autophagolysosome fusion, was determined
by the ratio of normalized intensities for LC3-II in inhibitor-treat-
ed versus untreated explants. Net flux was determined by sub-
tracting the normalized intensity of untreated LC3-II from the
corresponding inhibitor-treated value. Mouse liver LD fractions
were isolated as previously described (Singh et al. 2009). Methods
for immunohistochemistry are described in the Supplemental
Material.
Liver glycerol and triglyceride analyses
Liver glycerol was measured in tissue aqueous homogenates. Tri-
glyceride content was analyzed in liver samples subjected to lipid
extraction in a 2:1 chloroform:methanol mixture containing
0.05% sulfuric acid for 24 h at −20°C. Tissue glycerol and triglyc-
eride analyses were carried out using a commercial kit from
Sigma-Aldrich as per the manufacturer’s instructions.
Statistics
Results are expressed as mean ± SEM. Differences between ani-
mals and/or treatments were tested for statistical significance us-
ing Student’s unpaired t-test unless otherwise indicated.
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